Wall Street's best-performing analysts like these 5 stocks right now amid the market turmoilCNBC • 06/21/20
Genmab's stock surges after drug development deal with AbbView valued at up to nearly $4 billionMarket Watch • 06/10/20
Genmab A/S (GNMSF) CEO Jan van de Winkel on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20